Search results
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
The Yuma Sun· 1 day agoAmgen (NASDAQ:AMGN) today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency< ...
Dr. Loh: How do you know a new treatment is better?
VC Star | Ventura County Star via Yahoo News· 7 hours agoThe toughest standards in the world and the bellwether for the world’s approval are the U.S. Food and Drug Administration (USFDA) as well as the European...
EXO Biologics hopes to gain conditional marketing from Phase I/II BPD trial
Clinical Trials Arena via Yahoo Finance· 3 days agoEXO Biologics is hoping to receive conditional market approval from the European Medicines Agency...
Bristol Myers Gets CHMP Backing for Opdivo Combo in Bladder Cancer
Morningstar· 1 day agoBristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded ...
European Medicines Agency approves combination antibiotic for multidrug-resistant infections
Center for Infectious Disease Research and Policy· 5 days agoPfizer's novel combination antibiotic Emblaveo (aztreonam-avibactam) will be an option for...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 1 day agoApellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the European Medicines Agency (EMA) has reset the review of the marketing ...
Europe Recommends Three Cancer Drugs
Medscape· 2 days agoThe European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.
Commission approves superbug-busting antibiotic
Euronews via Yahoo News· 5 days agoThe European Commission today (22 April) authorised a new antibiotic designed to counter anti-bacterial resistance, one of the biggest health threats the...
J&J's RYBREVANT gets CHMP nod for lung cancer treatment By Investing.com
Investing.com· 1 day ago...Thursday marked a significant advancement for Johnson & Johnson (NYSE:JNJ) as the Committee for...
Drug for Overactive Bladder Recommended in Europe
Medscape· 2 days agoObgemsa is suitable for treating symptoms of an overactive bladder in adults, the European Medicines Agency has determined.
